Company Ticker News November 5, 2021Merck stock's biggest selloff in nearly 17 years is cutting close to 60 points off the Dow's price 0 0 Share
Company Ticker News November 4, 2021Merck's Covid Pill Molnupiravir Authorized For First Time In The U.K. 0 0 Share
Press Release November 4, 2021Merck Covid-19 treatment approved in UK as infection rate soars 0 0 Share
Company Ticker News November 2, 2021Merck Pushes Acceleron Buyout By Refiling For Antitrust Review 0 0 Share
Press Release November 1, 2021New Research for KEYTRUDA® (pembrolizumab) at Society for Melanoma Research (SMR) 2021 Congress Reinforces Merck's Commitment to Patients With Melanoma Across Stages of Disease 0 0 Share
Company Ticker News October 30, 2021Merck Announces Withdrawal and Refiling under the Hart-Scott-Rodino Act and Extension of Tender Offer to Acquire Acceleron Pharma Inc. 0 0 Share
Company Ticker News October 28, 2021Merck Sees Up To $1 Billion In Covid Antiviral Pill Sales—It Just Needs Regulatory Approval 0 0 Share
Company Ticker News October 23, 2021Can Merck's Antiviral for COVID Succeed Where Gilead's Failed? 0 0 Share
